Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts (Dr Morgan); Department of Population Health Sciences, Weill Cornell Medical College, New York, New York (Dr Murphy); Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts (Dr Assoumou, Dr Linas); Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts (Dr Assoumou, Dr Linas); and Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts (Dr Linas).
Ethical Considerations: Boston University institutional review board ruled this study not human subjects research (retrospective analysis of anonymous publicly available data).
Funding sources: This work was funded in part by the National Institute on Drug Abuse (R01DA046527 [Dr Morgan, Dr Linas], P30DA040500 [Dr Morgan, Dr Murphy, Dr Linas], and K23DA044085 [Dr Assoumou]) and the National Center for Injury Prevention and Control (R01CE002999 [Dr Morgan, Dr Murphy]).
Conflicts of interest: Dr Murphy consulted for Fresh Tonic Marketing on a project unrelated to this work.
Supplemental digital contents are available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.joem.org).
Address correspondence to: Jake R. Morgan, PhD, 715 Albany St, Talbot 340W, Boston, MA 02118 ([email protected]).
